NDC 50090-5642-01 - Digoxin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5642
- Requested NDC
- 50090-5642-01
- Package NDCs from labels
- 50090-5642-1, 50090-5642-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Digoxin - A-S Medication Solutions | A-S Medication Solutions | 2024-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5642-1 | Digoxin | 100 in 1 BOTTLE | TABLET | 100 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5642 | DIGOXIN TABLET [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240117_3d6afb9e-0c6c-40e1-ae26-6e544564ba44.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5642-1 | EA - Each | 50090-5642 | 6df7d0db-49db-47c5-81b6-2ef7809f2e2a | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aurovisc | HYPROMELLOSE OPHTHALMIC SOLUTION 2% W/V | Aurolab | e9100312-b105-50a6-e053-2a95a90ac31f | 2026-01-08 | Warnings | Z78RG6M2N2 |
| Digoxin | DIGOXIN | Northwind Health Company, LLC | f9897bec-c16f-2728-e053-6394a90aecb7 | 2026-01-01 | Warnings, Adverse reactions | 197604 73K4184T59 |
| Digoxin | DIGOXIN | ProPharma Distribution | 45b0d1e0-d1f6-28f6-e063-6394a90aaa51 | 2025-12-11 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Atlantic Biologicals Corps | dcf907d9-0f0e-4ecc-a555-7e6dcc08c166 | 2025-12-11 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Sandoz Inc | 58f45aba-ff6f-43cc-bb88-be40a9f7beda | 2025-12-08 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Amici Pharma, Inc | eda7193a-e139-41d5-a11b-dc6241645995 | 2025-10-31 | Warnings, Adverse reactions | 73K4184T59 |
| LANOXIN | DIGOXIN | Covis Pharma US, Inc | 9ec84cac-6ecc-43dc-8006-6ccc029e2707 | 2025-10-17 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Marlex Pharmaceuticals, Inc. | e104c3c5-e4b8-7dbd-e053-2995a90ae339 | 2025-10-08 | Warnings, Adverse reactions | 197604 73K4184T59 |
| Digoxin | DIGOXIN | Proficient Rx LP | 42d079a7-def1-4220-b71f-db2651966ffe | 2025-09-01 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | VistaPharm, LLC | ce62a741-a981-4880-8ce3-93269606a730 | 2025-06-30 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Hikma Pharmaceuticals USA Inc. | 3933b07f-5857-4a80-b502-e3214bdf9330 | 2025-06-07 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Hikma Pharmaceuticals USA Inc. | 1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf | 2025-04-10 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | American Health Packaging | 5500ee2a-077d-486c-b56d-36e0c5e5c31d | 2025-04-01 | Warnings, Adverse reactions | 197604 73K4184T59 |
| ImproVue Lubricant | HYPROMELLOSE 2208 (15000 MPA.S) | Oculus Surgical, Inc. | 63b82129-4848-47c5-bf92-ec4b1a9e9974 | 2025-01-22 | Warnings | Z78RG6M2N2 |
| VISCO SHIELD Lubricant | HYPROMELLOSE 2208 (15000 MPA.S) | OASIS Medical, Inc. | 72d22610-d8ab-4f24-b304-8b013430a7d7 | 2025-01-22 | Warnings | Z78RG6M2N2 |
| Digoxin | DIGOXIN | Medical Purchasing Solutions, LLC | 28f2c2cd-e58c-aea2-e063-6394a90a73e7 | 2024-12-10 | Warnings, Adverse reactions | 73K4184T59 |
| LANOXIN | DIGOXIN | Advanz Pharma (US) Corp. | d91e3646-4c63-4512-ab22-db39c085c4dc | 2024-12-05 | Warnings, Adverse reactions | 197604 73K4184T59 |
| Digoxin | DIGOXIN | Bryant Ranch Prepack | 03612934-62f4-4002-85af-6c66cd172acb | 2024-09-04 | Warnings, Adverse reactions | 73K4184T59 |
| Digoxin | DIGOXIN | Bryant Ranch Prepack | 4b893a4a-31e6-4a7a-b16c-02b1e578335b | 2024-09-04 | Warnings, Adverse reactions | 197604 73K4184T59 |
| Digoxin | DIGOXIN | AvPAK | 1cfd4e43-56f0-d182-e063-6394a90ad231 | 2024-07-11 | Warnings, Adverse reactions | 197604 73K4184T59 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.